Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Mean Expanded Disability Status Scale score change from baseline · patients with relapsing‐remitting multiple sclerosis

1 finding from 1 review

alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 221 participants
Very low

Mean Expanded Disability Status Scale score change from baseline · patients with relapsing‐remitting multiple sclerosis

1 finding from 1 review

alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1414 participants
Low